Chemical sympathectomy inhibits periodontal disease in Fischer 344 rats

Journal of Periodontal Research

Volumn 40, Issue 4, 2005, Pages 325-330

  Breivik, Torbjørn ^a,b,c   Gundersen, Yngvar ^b   Opstad, Per Kristian ^b   Fonnum, Frode ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

^c Department of Periodontology ^*  (Norway)

Author keywords

6 hydroxydopamine; Cytokines; Glucocorticoids; Periodontal disease; Sympathetic nervous system

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTERONE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OXIDOPAMINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BIOSYNTHESIS; CHEMICAL SYMPATHECTOMY; DRUG EFFECT; FISCHER 344 RAT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MENTAL STRESS; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; OSTEOLYSIS; PERIODONTAL DISEASE; RAT; REVIEW;

ALVEOLAR BONE LOSS; ANIMALS; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; OXIDOPAMINE; PERIODONTAL DISEASES; PITUITARY-ADRENAL SYSTEM; RATS; RATS, INBRED F344; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22144482762     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00803.x     Document Type: Review

References (37)

1. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994;15:504-511.
2. Ader R, Cohen N, Feiten D. Psychoneuroimmunology: Interactions between the nervous system and the immune system. Lancet 1995;345:99-103.
3. Maier SF, Watkins L. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;1:83-107.
4. Straub RH, Westerman J, Schoelmerich J, Falk W. Dialog between the CNS and the immune system in lymphoid organs. Immunol Today 1998;166:232-413.
5. Danzer R, Konsman JP, Bluthe RM, Kelly KW. Neural and hormonal path-ways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci 2000;85:60-65.
6. Hosoi T, Okuma Y, Nomura Y. The mechanisms of immune-to-brain communication in inflammation as a drug target. Curr Drug Targets Inflamm Allergy 2002;1:257-262.
7. Lorton D, Lubahn C, Klein N, Schaller J, Bellinger DL. Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis. Brain Behav Immun 1999;85:60-65.
8. Eskandari F, Sternberg EM. Neural immune interaction in health and disease. Ann New York Acad Sci 2002;966:20-27.
9. Breivik T, Thrane PS. Psychoneuroimmune interactions in periodontal disease. In: Ader R, Feiten DL, Cohen N, eds. Psychoneuroimmunology, 3rd edn. San Diego, CA: Academic Press, 2001: 627-644.
10. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1361.
11. Breivik T, Opstad PK, Gjermo P, Thrane PS. Effects of hypothalamic-pituitary-adrenal axis reactivity on periodontal tissue destruction in rats. Eur J Oral Sci 2000;108:115-122.
12. Breivik T, Thrane PS, Gjermo P, Opstad PK. Glucocorticoid receptor antagonist RU-486 treatment reduces periodontitis in Fischer 344 rats. J Periodont Res 2000;35:285-290.
13. Breivik T, Thrane PS, Gjermo P, Opstad PK, Pabst R, von Horsten S. Hypothalamic-pituitary-adrenal axis activation by experimental periodontal disease in rats. J Periodont Res 2001;36:295-300.
14. Sanders VM, Kasprowicz DJ, Kohm AP et al. Neurotransmitter receptors in lymphocytes and other lympoid cells. In: Ader R, Feiten D, Choen N, eds. Psychoneuroimmunology, 3rd edn. San Diego, CA: Academic Press, 2001, 161-196.
15. Madden KS. Catecholamines, sympathetic nerves, and immunity. In: Ader, R, Feiten, D, Choen, N, eds. Psychoneuroimmunology, 3rd edn. San Diego, CA: Academic Press, 2001, 161-196.
16. Feiten DL. Neural influence on immune responses: underlying suppositions and basic principles of neural-immune signalling. Prog Brain Res 2002;122:381-389.
17. Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/antiinflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 1999;10:359-368.
18. Piclo MJ. Methods of sympathetic denervation and alteration. J Auton Nerv Syst 1997;62:11-125.
19. Kostrzewa RM, Jacobowictz DM. Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 1974;26:199-288.
20. Cao L, Filipov NM, Lawrence DA. Sympathetic nervous system plays a major role in acute cold/restraint stress inhibition of host resistance to Listeria monocytogenes. J Neuroimmunol 2002;125:94-102.
21. Hugoson A, Ljungquist B, Breivik T. The relationship of some negative events and psychological factors to periodontal disease in an adult Swedish population 50-80 years of age. J Clin Periodont 2002;29:247-253.
22. Fokkema SJ, Loos BG, Siegte C, van der Velden U. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol 2002;127:374-378.
23. Breivik T, Rook GA. Prevaccination with SRL 172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. Clin Exp Immunol 2000;120:463-467.
24. Miura T, Kudo T, Matisuki A et al. Effects of 6-dydroxydopamine on host resistance against Listeria monocytogenes infection. Infect Immunol 2001;67:7234-7241.
25. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta-2-drenergic receptor by Th1 and Th2 clones: implication for cytokine production and B cell help. J Immunol 1997;158:4200-4210.
26. Van der Poll TJ, Jansen E, Endert HP, Sauerwein HP, van Deventer SJH. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 1994;62:2946-2050.
27. Bloomershine CS, Lafuce WP, Zwilling BC. Beta 2-adrenergic receptor stimulation inhibits nitric oxide generation by mycobacterium ovium infected macrophages. J Neuroimmunol 1999;101:68-75.
28. Szelenyi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha (2) - and beta adrenoreceptors in mice. J Neuroimmunol 2000;103:34-40.
29. Straub RH, Mayer M, Kreutz M, Leeb S, Schoelmerich J, Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukocyte Biol 2000;67: 553-558.
30. Lyte M, Ernst S, Driemeyer J, Aissa B. Strain-specific enhancement of splenic T cell mitogenesis and macrophage phagocytosis following peripheral axotomy. J Neuroimmunol 1991;31:1-8.
31. Madden KS, Stevens SY, Feiten DL, Bellinger DL. Alteration in T lymphocyte activity following chemical sympathectomy in young and old Fischer 344 rats. J Neuroimmunol 2000;103:131-145.
32. Molina PE. Noradrenergic inhibition of TNF upregulation in hemorrhagic shock. Neuroimmunomodulation 2001;91:125-133.
33. Chelmicka-Schorr E, Kwasniewski MN, Wollmann RL. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis. J Neuroimmunol 1992;37:99-103.
34. Leo NA, Bonneau RH. Mechanisms underlying chemical symphathectomy-induced suppression of herpes simplex virus-specific cytotoxic T lymphocyte activation and function. J Neuroimmunol 2000;110:45-56.
35. Rook GA. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:567-581.
36. Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 1998;161:5245-5251.
37. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 1998;91:4255-4264.